Why Doctors Are Watching Retatrutide Closely in 2026
The landscape of medical weight loss has shifted dramatically over the last few years, but the momentum isn’t slowing down. As we move through 2026, the medical community’s focus has intensified on the FDA obesity drug pipeline, specifically looking toward future fda obesity drugs that could redefine what is possible for adults with obesity. Among…

